Back

Serum light-chain neurofilament is associated with brain atrophy in patients with atrial fibrillation

1 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Atrial fibrillation pathophysiology and mechanisms Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Stefanie Aeschbacher

University Hospital Basel, Basel (Switzerland)

9 More presentations in this session

Presentation thumbnail
Doctor E. Mironova (Moscow, RU)
Abstract Slides
Presentation thumbnail
Doctor T. Tu (Changsha, CN)
Abstract Slides
Presentation thumbnail
Professor G. Tse (Hong Kong, CN)
Abstract
Presentation thumbnail
Doctor N. Kazem (Vienna, AT)
Abstract Slides
Presentation thumbnail
Doctor P. Buettner (Leipzig, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Atrial fibrillation pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2019

1 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Elevated plasma amyloid, tau and neurofilament light chain suggest high prevalence of ongoing neurodegenerative processes in HFrEF and are linked to worse survival
20 May 2023
thumbnail
Congress Presentation
Atrial fibrosis, atrial volume and implantable loop recorder-detected atrial fibrillation in embolic stroke
1 April 2025
thumbnail
Congress Presentation
Association of estimated glomerular filtration rate differences with brain lesions in patients with atrial fibrillation
12 April 2026
thumbnail
Congress Presentation
Risk of dementia in patients treated with non-vitamin k antagonist oral anticoagulant or warfarin for nonvalvular atrial fibrillation
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources